Tradestie Institutional Equity Comparison Engine

AARD vs HCHL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AARD Overall Edge

AARD Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aardvark Therapeutics, Inc. Common Stock (AARD) driven by superior Growth & Margin, Options & Structure while HCHL counters with relative strength in Momentum & Technical. Fundamentally, AARD trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus HCHL at N/M Forward P/E and -101.6% operating margin (-45.7% YoY). In options structure, AARD sits in UNCLASSIFIED (26th %ile IV; Dealer Gamma Walls on Pro) against HCHL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
AARD N/M vs HCHL N/M Fwd P/E
Growth & Margin Winner AARD
Op Margin 0.0% vs -101.6% ยท YoY +0.0% vs -45.7%
Momentum & Technical Winner HCHL
1Y -89.8% vs -20.8% ยท 52W Pos 1% vs 49%
Options & Structure Winner AARD
UNCLASSIFIED (26th %ile IV) vs UNCLASSIFIED (N/A IV)
AARD NASDAQ
Aardvark Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$1.00
+9.89% 1D
Market Cap $19.9M
1M Return -77.32%
1Y Return -89.84%
Forward P/E N/M
Unified AI Score
46.4 / 100 HOLD
Tech 35.0 Fund 49.0 Flow 68.0 Mom 63.9
HCHL NASDAQ
Happy City Holdings Limited Class A Ordinary shares
Retail-Eating Places
$3.96
-1.49% 1D
Market Cap $120.0M
1M Return +36.55%
1Y Return -20.8%
Forward P/E N/M
Unified AI Score
45.1 / 100 HOLD
Tech 55.0 Fund 46.0 Flow 50.0 Mom 27.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AARD -89.84% HCHL -20.8% Spread: +89.93 pp (HCHL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AARD TTM Op. Margin: 0.0% HCHL TTM Op. Margin: -101.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AARD vs HCHL. Trailing 12-month operating profitability (AARD 0.0% vs HCHL -101.6%) and valuation multiples (AARD N/M vs HCHL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AARD (5) vs HCHL (3)
Institutional Metric AARD HCHL Criterion Row Winner
Market Capitalization Scale $19.9M $120.0M Larger Scale HCHL
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -45.7% Higher Growth AARD
Operating Margin (TTM) Profitability 0.0% -101.6% Higher Margin AARD
Net Profit Margin Profitability 0.0% -35.7% Higher Margin AARD
Return on Equity (ROE) Capital Efficiency -66.0% -173.0% Higher ROE AARD
52-Week Range Position Momentum 1% ($1โ€“$17) 49% ($1โ€“$7) Stronger Trend HCHL
Beta / 30D Volatility Risk Regime 4.01ฮฒ ยท 285% Vol -0.84ฮฒ ยท 94% Vol Lower Realized Risk HCHL
Unified Institutional Score Composite Signal 46.4 / 100 (HOLD) 45.1 / 100 (HOLD) Higher Composite AARD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AARD vs HCHL Buy Guide
AARD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 26th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live AARD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
HCHL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live HCHL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AARD nor HCHL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.